Panorama NIPT: Understanding Non-Invasive Prenatal Genetic Screening

# Panorama NIPT: Understanding Non-Invasive Prenatal Genetic Screening

Pregnancy is an exciting journey, but it can also bring many questions about a baby’s health and development. Advances in prenatal genetic screening now allow expectant parents and healthcare professionals to gain important information about certain chromosomal conditions early in pregnancy through a simple blood test.

One of these screening options is Panorama™ Non-Invasive Prenatal Testing (NIPT), developed by Natera. Panorama is a blood-based prenatal screening test designed to assess the likelihood of certain chromosomal conditions that may affect a developing baby.

What Is Panorama NIPT?

Panorama is a form of non-invasive prenatal testing, commonly known as NIPT. The test analyzes genetic information found in a pregnant person’s blood to estimate the probability of specific chromosomal abnormalities in the pregnancy.

Unlike diagnostic procedures such as amniocentesis or chorionic villus sampling (CVS), Panorama only requires a blood sample from the pregnant patient. This makes the screening process non-invasive and allows testing to be performed relatively early in pregnancy.

According to Natera, Panorama can be performed from as early as nine weeks of gestation.

How Does Panorama Work?

During pregnancy, small fragments of DNA associated with the pregnancy circulate in the pregnant person’s bloodstream. These fragments are commonly referred to as cell-free DNA, or cfDNA.

Panorama uses single nucleotide polymorphism (SNP)-based technology to analyze genetic differences within this DNA. The technology is designed to distinguish genetic information associated with the pregnant person from that associated with the pregnancy.

By evaluating thousands of SNPs, Panorama can assess the likelihood of several chromosomal conditions.

What Conditions Can Panorama Screen For?

Depending on the screening options ordered by the healthcare provider and the circumstances of the pregnancy, Panorama may screen for several chromosomal conditions.

These can include common trisomies such as:

• Trisomy 21 (Down syndrome)
• Trisomy 18 (Edwards syndrome)
• Trisomy 13 (Patau syndrome)

Panorama may also provide screening for certain sex chromosome abnormalities, including Monosomy X (Turner syndrome), XXY syndrome (Klinefelter syndrome), Triple X syndrome and XYY syndrome.

Certain screening options may also evaluate conditions associated with chromosomal microdeletions, including 22q11.2 deletion syndrome.

One notable feature described by Natera is Panorama's ability to screen for triploidy, a chromosomal abnormality in which a pregnancy has an additional complete set of chromosomes.

The exact conditions included in an individual's screening can vary, so patients should discuss the available screening options with their healthcare provider.

Panorama NIPT in Singleton and Twin Pregnancies

Panorama can be used in both singleton and certain twin pregnancies.

However, the screening options available may differ depending on whether the pregnancy involves one baby, identical twins, non-identical twins, donor eggs or a gestational carrier.

For this reason, the appropriate testing strategy should always be determined together with a qualified healthcare professional.

When Can the Panorama Test Be Performed?

One of the advantages of NIPT is the ability to obtain genetic screening information relatively early in pregnancy.

Panorama can be performed starting at approximately nine weeks of pregnancy.

The process generally begins with a blood sample. The sample is then sent to a laboratory where the genetic material is analyzed.

According to Natera, most Panorama results are returned to the ordering healthcare provider within approximately 5–7 calendar days after the laboratory receives the sample.

Understanding Panorama Results

Panorama results are intended to estimate whether a pregnancy has a higher or lower probability of certain chromosomal conditions.

A low-risk result generally indicates that the probability of the screened condition is reduced, while a high-risk result indicates an increased probability.

However, this distinction is extremely important:

Panorama is a screening test, not a diagnostic test.

A high-risk result does not confirm that a baby has a particular genetic condition. Similarly, screening cannot completely rule out every possible genetic or developmental condition.

If a screening result indicates an increased risk, a healthcare provider may recommend additional evaluation or diagnostic testing.

Screening vs. Diagnostic Testing

Understanding the difference between prenatal screening and diagnostic testing is essential.

Screening tests such as NIPT estimate the probability of certain conditions. Diagnostic procedures are designed to determine more definitively whether a specific chromosomal abnormality is present.

Depending on the pregnancy and screening results, diagnostic options may include:

Chorionic Villus Sampling (CVS): A diagnostic procedure that analyzes placental tissue.

Amniocentesis: A diagnostic procedure that analyzes a sample of amniotic fluid surrounding the developing baby.

These procedures should be discussed carefully with an obstetrician, maternal-fetal medicine specialist or genetic counselor.

Why Is Early Prenatal Genetic Screening Important?

Prenatal genetic screening can provide families and healthcare professionals with additional information during pregnancy.

Early information may help healthcare teams determine whether additional testing or monitoring should be considered. It can also give families more time to understand a potential genetic condition, consult specialists and prepare for additional medical care when necessary.

However, genetic screening is a personal medical decision. The benefits, limitations and possible outcomes should be considered with guidance from a qualified healthcare professional.

The Role of Genetic Counseling

Genetic information can sometimes be complex, particularly when screening results indicate an increased risk or produce an unexpected finding.

Genetic counselors can help patients understand:

• What the screening result means
• The limitations of prenatal screening
• The probability associated with a particular result
• Whether diagnostic testing may be appropriate
• What additional testing options are available

This can be particularly valuable before making medical decisions based on a prenatal screening result.

Important Limitations of NIPT

Although modern NIPT technologies can provide valuable information, no prenatal screening test can identify every genetic condition or guarantee the health of a baby.

Results should therefore be interpreted within the broader clinical context of the pregnancy, including medical history, ultrasound findings and other prenatal assessments.

A high-risk screening result should generally be evaluated through appropriate medical consultation and, when indicated, diagnostic testing before major pregnancy-related medical decisions are made.

Final Thoughts

Panorama NIPT represents one of the modern approaches to early prenatal genetic screening. Using a blood sample and SNP-based technology, the test can assess the likelihood of several chromosomal conditions from early pregnancy.

Its non-invasive nature and early testing window make NIPT an important option within contemporary prenatal care.

At the same time, expectant parents should remember that Panorama provides screening information rather than a definitive diagnosis. Results should always be reviewed with a healthcare professional who can explain their clinical significance and discuss whether further testing is appropriate.

For individuals considering prenatal genetic screening, speaking with an obstetrician or genetic counselor can help determine whether NIPT is appropriate for their pregnancy and which screening options best match their individual circumstances.

Medical Disclaimer: This article is provided for general educational and informational purposes only. It is not intended to provide medical advice, diagnosis or treatment. Prenatal screening options, test availability and clinical recommendations may vary according to individual circumstances and location. Always discuss prenatal testing and medical decisions with a qualified healthcare professional.